The latest announcement is out from RepliCel Life Sciences ( ($TSE:RP) ). RepliCel Life Sciences announced the completion of ...
BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences ...
New England Biolabs Inc. reached a class settlement with workers who say they were wrongly forced to sell their company stock at an unfair price.
Saba Capital Management, L.P., a significant shareholder in abrdn Life Sciences Investors (NYSE:HQL), recently reported the sale of 62,743 shares of common stock, amounting to a total value of ...
Life science real estate developer Breakthrough Properties bought the three-building Muse complex at 3030, 3040 and 3050 ...
Lake Street initiated coverage of TriSalus Life Sciences (TLSI) with a Buy rating and $10 price target TriSalus is commercializing its ...